BioRelix

About:

BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.

Website: http://www.biorelix.com

Top Investors: Alexandria Real Estate Equities, OpGen, Connecticut Innovations, Novartis Venture Fund, New Leaf Venture Partners

Description:

BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.